BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28819757)

  • 1. Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.
    Prado MJ; de Castro SM; Kopacek C; de Mello MP; Rispoli T; Grandi T; da Silva CMD; Rossetti MLR
    Mol Diagn Ther; 2017 Dec; 21(6):663-675. PubMed ID: 28819757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
    Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
    Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP21A2 mutation analysis in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay.
    Hong G; Park HD; Choi R; Jin DK; Kim JH; Ki CS; Lee SY; Song J; Kim JW
    Ann Lab Med; 2015 Sep; 35(5):535-9. PubMed ID: 26206692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development and application of a method for molecular diagnosis of 21-hydroxylase deficiency].
    Ma DY; Sun Y; Chen Y; Yang B; Cheng J; Huang ML; Zhang J; Zhang JJ; Hu P; Lin Y; Jiang T; Xu ZF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):49-54. PubMed ID: 23450479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of CYP21A2 gene mutations among patients with classical steroid 21-hydroxylase deficiency].
    Su Y; Chen H; Zhu W; Wang J; Zhou J; Chen Y; Zhao H; Zeng Y; Lin F; Zhang H; Lin Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):786-791. PubMed ID: 27984606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the CYP21A2 Gene Mutations in Children with Classic Congenital Adrenal Hyperplasia.
    Saraf S; Srivastava P; Panigrahi I; Seenappa V; Kumar R; Yadav J; Daniel R; Dayal D
    Indian J Pediatr; 2024 Feb; 91(2):137-142. PubMed ID: 35094236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report.
    Concolino P; Mello E; Toscano V; Ameglio F; Zuppi C; Capoluongo E
    Clin Chim Acta; 2009 Apr; 402(1-2):164-70. PubMed ID: 19263525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
    J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
    Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
    J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
    Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP21A2 Gene Pathogenic Variants: A Multicenter Study on Genotype-Phenotype Correlation from a Portuguese Pediatric Cohort.
    Santos-Silva R; Cardoso R; Lopes L; Fonseca M; Espada F; Sampaio L; Brandão C; Antunes A; Bragança G; Coelho R; Bernardo T; Vieira P; Morais R; Leite AL; Ribeiro L; Carvalho B; Grangeia A; Oliveira R; Oliveira MJ; Rey V; Rosmaninho-Salgado J; Marques B; Garcia AM; Meireles A; Carvalho J; Sequeira A; Mirante A; Borges T;
    Horm Res Paediatr; 2019; 91(1):33-45. PubMed ID: 30889569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
    de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
    Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.
    Liu Y; Zheng J; Liu N; Xu X; Zhang X; Zhang Y; Li G; Liu G; Cai C; Shu J
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1501. PubMed ID: 32959514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China.
    Su L; Yin X; Cheng J; Cai Y; Wu D; Feng Z; Liu L
    Clin Chim Acta; 2018 Nov; 486():142-150. PubMed ID: 30048636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia.
    Jang JH; Jin DK; Kim JH; Tan HK; Kim JW; Lee SY; Ki CS; Park HD
    Ann Clin Lab Sci; 2011; 41(1):44-7. PubMed ID: 21325254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinical phenotypes and CYP21A2 gene variants in 18 patients with 21-hydroxylase deficiency].
    Zheng R; Zhang L; Yuan Q; Man H; Yang J; Wang Y; Hu Z; Zhang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Feb; 36(2):120-123. PubMed ID: 30703227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
    Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
    Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
    Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
    Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
    J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.